Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-12-01 Sale | 2022-12-20 4:05 pm | Oncocyte Corp | OCX | Ross Douglas T. Former CSO. | 150,000 | $0 | $0 | 298,545 (Direct) | View |
| 2022-03-25 Purchase | 2022-03-28 8:00 pm | Oncocyte Corp | OCX | Ross Douglas T. Chief Scientific Officer | 15,000 | $1.4 | $21,000 | 20,317 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-12-21 Option Award | 2022-12-22 6:57 pm | N/A N/A | Oncocyte Corp | OCX | Ross Douglas T. Former CSO | 213,797 | $0 | 234,114 (Direct) | View |
| 2022-08-15 Option Award | 2022-08-17 8:24 pm | N/A N/A | Oncocyte Corp | OCX | Ross Douglas T. Chief Scientific Officer | 150,000 | $0 | 170,317 (Direct) | View |
| 2022-03-15 Option Award | 2022-03-17 9:29 pm | N/A 2032-03-15 | Oncocyte Corp | OCX | Ross Douglas T. Chief Scientific Officer | 200,000 | $0 | 200,000 (Direct) | View |